《结节性硬化症相关肾血管平滑肌脂肪瘤诊治专家共识》解读
|
摘要
《结节性硬化症相关肾血管平滑肌脂肪瘤诊治专家共识》(简称《共识》)自2017年发表以来受到临床医师尤其是泌尿外科医师的高度关注。本文对《共识》结合临床进行解读,讨论结节性硬化症相关肾血管平滑肌脂肪瘤的诊断和治疗,以供读者参阅、借鉴。
Since the publication of the Expert Consensus on Diagnosis and Treatment of Renal Angioleiomyolipoma Associated with Tuberous Sclerosis, it has attracted the attention of clinicians, especially urologists. In this paper, we will discuss the diagnosis and treatment of renal angiomyolipoma associated with tuberous sclerosis by interpreting the Consensus in combination with clinical practice for readers' reference.
Since the publication of the Expert Consensus on Diagnosis and Treatment of Renal Angioleiomyolipoma Associated with Tuberous Sclerosis, it has attracted the attention of clinicians, especially urologists. In this paper, we will discuss the diagnosis and treatment of renal angiomyolipoma associated with tuberous sclerosis by interpreting the Consensus in combination with clinical practice for readers' reference.
引文
[1] 中华医学会泌尿外科学分会.结节性硬化症相关肾血管平滑肌脂肪瘤诊治专家共识[J].中华泌尿外科杂志,2017, 38(5): 321-325.
[2] Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study[J].PLoS One,2017,12(8):e0180939. doi: 10.1371/journal.pone.0180939. eCollection 2017.
[3] Bissler JJ, Kingswood JC. Renal angiomyolipomata[J]. Kidney Int. 2004;66(3):924-934.
[4] Eijkemans MJ, van der Wal W, Reijnders LJ, et al. Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: An observational study in tuberous sclerosis complex patients in the Netherlands[J]. Am J Kidney Dis,2015,66(4):638-645.
[5] Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma[J]. J Urol,2002,168(4 Pt 1):1315-1325.
[6] Yamakado K, Tanaka N, Nakagawa T, et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture[J]. Radiology, 2002;225(1):78-82.
[7] Siroky BJ, Yin H, Bissler JJ. Clinical and molecular insights into tuberous sclerosis complex renal disease[J]. Pediatr Nephrol,2011,26(6):839-852.
[8] Sun P, Liu J, Charles H, et al. Outcomes of angioembolization and nephrectomy for renal angiomyolipoma associated with tuberous sclerosis complex: a real-world US national study[J]. Curr Med Res Opin,2017,33(5):821-827.
[2] Bissler JJ, Kingswood JC, Radzikowska E, et al. Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study[J].PLoS One,2017,12(8):e0180939. doi: 10.1371/journal.pone.0180939. eCollection 2017.
[3] Bissler JJ, Kingswood JC. Renal angiomyolipomata[J]. Kidney Int. 2004;66(3):924-934.
[4] Eijkemans MJ, van der Wal W, Reijnders LJ, et al. Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: An observational study in tuberous sclerosis complex patients in the Netherlands[J]. Am J Kidney Dis,2015,66(4):638-645.
[5] Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma[J]. J Urol,2002,168(4 Pt 1):1315-1325.
[6] Yamakado K, Tanaka N, Nakagawa T, et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture[J]. Radiology, 2002;225(1):78-82.
[7] Siroky BJ, Yin H, Bissler JJ. Clinical and molecular insights into tuberous sclerosis complex renal disease[J]. Pediatr Nephrol,2011,26(6):839-852.
[8] Sun P, Liu J, Charles H, et al. Outcomes of angioembolization and nephrectomy for renal angiomyolipoma associated with tuberous sclerosis complex: a real-world US national study[J]. Curr Med Res Opin,2017,33(5):821-827.